Wolfson Wohl Cancer Research Centre

Wolfson Wohl Cancer Research Centre is a leading cancer research facility located at the University of Glasgow, in close proximity to the Beatson West of Scotland Cancer Centre and the Institute of Cancer Sciences. The centre is named after the Wolfson Foundation and The Wohl Foundation, which have provided significant funding for its establishment and operations, similar to the Wellcome Trust and the Cancer Research UK. The centre's research focuses on understanding the biology of cancer and developing new treatments, in collaboration with institutions like the National Cancer Institute and the European Organisation for Research and Treatment of Cancer.

● Overview

The Wolfson Wohl Cancer Research Centre is a state-of-the-art facility that brings together researchers from various disciplines, including molecular biology, cell biology, and biochemistry, to tackle the complex challenges of cancer research, much like the Broad Institute and the Sanger Institute. The centre's team includes renowned scientists like James Allison, Tasuku Honjo, and Emmanuelle Charpentier, who have made significant contributions to the field of cancer research, including the development of immunotherapy and gene editing techniques like CRISPR. The centre's research is focused on understanding the underlying mechanisms of cancer development and progression, with the goal of developing new and effective treatments, in partnership with organizations like the American Cancer Society and the International Union Against Cancer.

● History

The Wolfson Wohl Cancer Research Centre was established in 2011, with funding from the Wolfson Foundation and The Wohl Foundation, as well as support from the University of Glasgow and the Scottish Government. The centre's founding director was Professor Karen Vousden, a renowned cancer researcher who has made significant contributions to the field, including the discovery of the p53 tumor suppressor gene, similar to the work of Professor David Lane and Professor Arnold Levine. Since its establishment, the centre has grown to become one of the leading cancer research facilities in the UK, with a team of over 100 researchers and support staff, including Professor Charles Swanton and Professor Caroline Springer.

● Research

The Wolfson Wohl Cancer Research Centre is involved in a wide range of research activities, including the study of cancer stem cells, tumor microenvironment, and cancer metabolism, in collaboration with institutions like the Francis Crick Institute and the German Cancer Research Center. The centre's researchers use cutting-edge techniques like single-cell analysis and CRISPR gene editing to understand the complex biology of cancer, similar to the work of Professor Jennifer Doudna and Professor Feng Zhang. The centre is also involved in the development of new cancer therapies, including immunotherapy and targeted therapy, in partnership with companies like Pfizer and AstraZeneca.

● Facilities

The Wolfson Wohl Cancer Research Centre is located in a state-of-the-art facility that provides researchers with access to cutting-edge equipment and technology, including flow cytometry, mass spectrometry, and next-generation sequencing, similar to the facilities at the Wellcome Sanger Institute and the National Institutes of Health. The centre also has a range of specialized facilities, including a tissue culture laboratory, a molecular biology laboratory, and a bioinformatics suite, which are used by researchers like Professor Michael Stratton and Professor Serena Nik-Zainal. The centre's facilities are designed to support collaborative research and provide a stimulating environment for scientists to work together to tackle the challenges of cancer research, in partnership with organizations like the Cancer Genome Atlas and the International Cancer Genome Consortium.

● Notable Achievements

The Wolfson Wohl Cancer Research Centre has made several notable achievements since its establishment, including the discovery of new cancer genes and the development of new cancer therapies, similar to the work of Professor Brian Druker and Professor Nicholas Lydon. The centre's researchers have published numerous papers in top-tier scientific journals, including Nature, Science, and Cell, and have received several awards and honors for their contributions to cancer research, including the Lasker Award and the Breakthrough Prize in Life Sciences. The centre has also established partnerships with several leading cancer research institutions, including the National Cancer Institute and the European Organisation for Research and Treatment of Cancer, and has collaborated with companies like Roche and Merck to develop new cancer treatments.

● Funding and Partnerships

The Wolfson Wohl Cancer Research Centre is funded by a range of organizations, including the Wolfson Foundation, The Wohl Foundation, and the University of Glasgow, as well as Cancer Research UK and the Scottish Government. The centre has also established partnerships with several leading cancer research institutions, including the National Cancer Institute and the European Organisation for Research and Treatment of Cancer, and has collaborated with companies like Pfizer and AstraZeneca to develop new cancer treatments, similar to the partnerships between the Broad Institute and IBM and between the Sanger Institute and Illumina. The centre's funding and partnerships have enabled it to support a wide range of research activities and to make significant contributions to the field of cancer research, in collaboration with organizations like the American Association for Cancer Research and the European Cancer Organisation. Category:Cancer research